Quantitative analysis for Ekso Bionics Holdings, Inc. Common Stock (CHRN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (70.0) (grade B). 30 signals analyzed (25 differentiated alt-data).
CHRN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $11.62 | $10.96 | $11.44 |
| 2026-05-11 | $16.60 | $14.32 | $14.43 |
| 2026-05-21 | $16.29 | $13.50 | $15.90 |
| 2026-06-03 | $19.83 | $17.58 | $19.04 |
| 2026-06-15 | $20.48 | $18.87 | $19.15 |
| 2026-06-26 | $22.46 | $19.89 | $22.23 |
| 2026-07-09 | $20.85 | $18.02 | $20.34 |
| 2026-07-21 | $29.45 | $23.63 | $25.38 |
| 2026-07-31 | $22.50 | $20.51 | $22.03 |
| 2026-08-12 | $21.30 | $19.80 | $20.79 |
| 2026-08-24 | $25.00 | $22.27 | $22.57 |
| 2026-09-03 | $20.66 | $18.80 | $20.08 |
How Ekso Bionics Holdings, Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. Common Stock | $56M | — |
| PDSB | PDS Biotechnology Corporation | $57M | — |
| BGM | BGM Group Ltd. | $59M | — |
| CUE | Cue Biopharma, Inc. | $54M | — |
View all Health Care stocks by valuation and signals →
Ekso Bionics Holdings, Inc. Common Stock (CHRN) scores Buy (70.0), with no measured dimension below 53. Its highest are earnings quality at 97, ML forecast at 92, valuation at 72, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| earnings quality | 97 |
| ML forecast | 92 |
| valuation | 72 |
| competitive moat | 70 |
| technicals | 53 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Ekso Bionics Holdings, Inc. Common Stock (CHRN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/CHRN"><img src="https://stoquant.com/badge/CHRN.svg" alt="Ekso Bionics Holdings, Inc. Common Stock (CHRN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.